Dr. Jan-Olav Henck has been named chief scientific officer at Aptuit. Dr. Henck will report to Stuart E. Needleman, president of Aptuit Scientific Operations. Aptuit’s chief executive officer, Tim Tyson, commented that the establishment of the CSO role reflects the company’s commitment to provide scientific expertise and strongly supports Aptuit’s focus to engineer a better drug development process through scientific excellence. Mr. Tyson explained, “Science is at the forefront of our mis...